Avanos Medical Inc (AVNS)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 55.44% | 55.86% | 56.17% | 56.68% | 56.00% | 55.30% | 54.99% | 54.82% | 54.77% | 53.91% | 52.63% | 49.94% | 48.93% | 48.40% | 49.02% | 50.69% | 52.22% | 54.77% | 55.76% | 56.81% |
| Operating profit margin | -55.68% | 8.47% | 6.87% | 4.22% | 3.39% | 3.72% | 5.82% | 8.17% | 8.91% | 9.03% | 7.30% | 4.01% | 1.20% | -8.27% | -8.76% | -8.26% | -6.45% | -0.63% | -3.19% | -4.27% |
| Pretax margin | -58.64% | 3.83% | 2.05% | 0.40% | 0.11% | 2.11% | 4.41% | 6.88% | 7.84% | 8.13% | 6.63% | 3.53% | 0.78% | -8.95% | -9.89% | -9.89% | -8.46% | -2.72% | -5.06% | -5.76% |
| Net profit margin | -57.01% | 2.30% | 1.13% | -9.15% | -8.76% | -7.39% | -4.61% | 5.34% | 6.07% | 5.39% | -1.02% | 2.44% | 0.70% | -7.06% | 0.33% | -5.38% | -3.81% | 1.93% | -2.40% | -3.07% |
Avanos Medical Inc's profitability ratios have shown some fluctuations over the years. The gross profit margin has generally been stable, ranging from 48.40% to 56.68%, indicating the company's ability to generate profits from its core operations.
However, the operating profit margin has been more volatile, fluctuating from -55.68% to 9.03%. This suggests that the company has faced challenges in controlling its operating expenses and improving operational efficiency.
The pretax margin has also shown variability, ranging from -58.64% to 8.13%. This indicates fluctuations in the company's ability to generate profits before accounting for taxes, potentially due to changes in operating income and non-operating expenses.
Lastly, the net profit margin has fluctuated between -9.15% and 6.07%, reflecting the company's overall bottom-line profitability after accounting for all expenses. The negative margins in certain periods indicate that the company experienced periods of losses.
Overall, Avanos Medical Inc's profitability ratios show a mixed performance, with some periods of profitability and others with challenges in controlling costs and generating profits. Further analysis of the underlying factors driving these ratios would be necessary to understand the company's financial performance in depth.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -33.18% | 3.48% | 2.83% | 1.73% | 1.41% | 1.62% | 2.72% | 3.83% | 4.09% | 4.05% | 3.24% | 1.73% | 0.56% | -3.81% | -3.84% | -3.58% | -2.76% | -0.25% | -1.28% | -1.73% |
| Return on assets (ROA) | -33.97% | 0.95% | 0.46% | -3.74% | -3.65% | -3.21% | -2.16% | 2.51% | 2.79% | 2.42% | -0.45% | 1.05% | 0.33% | -3.25% | 0.14% | -2.34% | -1.63% | 0.77% | -0.96% | -1.24% |
| Return on total capital | -46.57% | 4.12% | 3.28% | 2.24% | 1.12% | 1.80% | 2.66% | 3.46% | 4.66% | 4.61% | 4.15% | 2.67% | 0.95% | -4.57% | -4.96% | -4.68% | -3.57% | -0.19% | -1.53% | -2.03% |
| Return on equity (ROE) | -47.33% | 1.28% | 0.63% | -5.07% | -5.00% | -4.53% | -2.92% | 3.35% | 3.86% | 3.40% | -0.63% | 1.48% | 0.41% | -4.12% | 0.19% | -3.07% | -2.16% | 1.08% | -1.34% | -1.74% |
The profitability ratios of Avanos Medical Inc have shown fluctuations over the period under consideration.
1. Operating return on assets (Operating ROA) has improved from negative figures in 2020 and 2021 to positive values from March 2022 to December 2024, indicating that the company has been able to generate operating profits relative to its assets in the more recent periods.
2. Return on assets (ROA) also started as negative in 2020 and 2021 before turning positive from September 2022 to September 2024. This ratio provides a broader view of overall profitability, and the positive values in the latter periods suggest improved overall profitability relative to the total assets.
3. Return on total capital demonstrates a similar trend with negative values in 2020 and 2021 turning positive from March 2022 onwards. This indicates that the company has been able to generate returns for both equity and debt holders in the more recent periods.
4. Return on equity (ROE) shows a pattern of improvement from negative values in 2020 and 2021 to positive figures from March 2022 to September 2024. This suggests a better return on shareholders' equity, reflecting a positive trend in the company's ability to generate profits for its shareholders.
Overall, the profitability ratios of Avanos Medical Inc have shown an upward trajectory from 2020 to 2024, indicating a positive trend in the company's ability to generate profits and returns for its investors and stakeholders.